Education
About Us
Working with TipRanks
Follow Us
Viemed Healthcare US (VMD)
:VMD
VMD Stock Chart & Stats
$6.85
$0.08(0.94%)
At close: 4:00 PM EST
$6.85
$0.08(0.94%)
Day’s Range― - ―
52-Week Range$5.93 - $9.81
Previous CloseN/A
Volume27.16K
Average Volume (3M)169.06K
Market Cap
$253.66M
Enterprise Value$272.66M
Total Cash (Recent Filing)$20.02M
Total Debt (Recent Filing)$6.89M
Price to Earnings (P/E)19.3
Beta1.08
Next Earnings
Nov 05, 2025EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding38,785,760
10 Day Avg. Volume139,248
30 Day Avg. Volume169,059
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue1.13
Enterprise Value/Gross Profit1.95
Enterprise Value/Ebitda5.75
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Viemed Healthcare News
VMD FAQ
What was Viemed Healthcare US’s price range in the past 12 months?
Viemed Healthcare US lowest stock price was $5.93 and its highest was $9.81 in the past 12 months.
What is Viemed Healthcare US’s market cap?
Viemed Healthcare US’s market cap is $253.66M.
When is Viemed Healthcare US’s upcoming earnings report date?
Viemed Healthcare US’s upcoming earnings report date is Nov 05, 2025 which is in 5 days.
How were Viemed Healthcare US’s earnings last quarter?
Viemed Healthcare US released its earnings results on Aug 06, 2025. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.085 by -$0.005.
Is Viemed Healthcare US overvalued?
According to Wall Street analysts Viemed Healthcare US’s price is currently Overvalued.
Does Viemed Healthcare US pay dividends?
Viemed Healthcare US does not currently pay dividends.
What is Viemed Healthcare US’s EPS estimate?
Viemed Healthcare US’s EPS estimate is 0.09.
How many shares outstanding does Viemed Healthcare US have?
Viemed Healthcare US has 38,785,760 shares outstanding.
What happened to Viemed Healthcare US’s price movement after its last earnings report?
Viemed Healthcare US reported an EPS of $0.08 in its last earnings report, missing expectations of $0.085. Following the earnings report the stock price went up 7.907%.
Which hedge fund is a major shareholder of Viemed Healthcare US?
Currently, no hedge funds are holding shares in VMD
Viemed Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
VMD Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 14.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $402.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 0.1%
Last 30 Days ▼ 0.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.73%
12-Months-Change
Fundamentals
Return on Equity
10.79%
Trailing 12-Months
Asset Growth
12.60%
Trailing 12-Months
Company Description
Viemed Healthcare US
Viemed Healthcare (VMD) is a leading provider of home-based healthcare solutions, specializing in the management of patients with chronic respiratory diseases. The company operates primarily in the healthcare sector, offering products and services such as ventilators, oxygen therapy devices, and related clinical support. Viemed is committed to improving patient outcomes and quality of life through innovative healthcare delivery models and personalized care plans.
VMD Company Deck
VMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance in core and complementary business areas, highlighted by consistent growth in ventilation and rapid expansion in sleep therapy and resupply. Strategic acquisitions and positive regulatory changes further bolstered the company's outlook. While there was a noted slowdown in the staffing segment and a slight decrease in gross margin, the overall narrative was one of robust growth and strategic positioning.View all VMD earnings summariesTechnical Analysis
Ownership Overview
13.05% Insiders
16.01% Mutual Funds
0.96% Other Institutional Investors
62.40% Public Companies and
Individual Investors